Bradley named Executive Vice Chairman of Winship's Department of Radiation Oncology

Woodruff Health Sciences Center | Aug. 7, 2019

Contact

Judy Fortin
Senior Director, Winship Communications
404-778-4580
judy.fortin@emory.edu

Story image

Jeffrey Bradley, MD, FASTRO, will become the new executive vice chairman of the Department of Radiation Oncology at Winship cancer Institute of Emory University.

PrintPrint

Winship Cancer Institute of Emory University has announced that Jeffrey Bradley, MD, FASTRO, will become the new executive vice chairman of the Department of Radiation Oncology effective September 3, 2019.

Bradley comes to Winship from Washington University School of Medicine in St. Louis where he was the S. Lee Kling Endowed Professor of Radiation Oncology, clinical director of the Kling Proton Center, and chief of the Radiation Oncology Thoracic Cancer Service.

"Jeff successfully led the development of the first single room proton center in the world at Barnes Jewish in St Louis," says Walter J. Curran, Jr., MD, Winship's executive director and chair of the Department of Radiation Oncology. "He has served as NRG Oncology's Lung Cancer Committee Chairman since 2010 and has led an extraordinary portfolio of transformational clinical trials for lung cancer patients."

A graduate of the University of Arkansas for Medical Sciences, Bradley completed his residency at the University of Chicago Medical Center. He joined the faculty at Washington University School of Medicine in 1998. In addition to thoracic malignancies, he also focuses on stereotactic body radiation therapy and proton beam therapy. He will continue in his role as Lung Cancer Committee Chairman within NRG Oncology, the largest of the four adult National Clinical Trials Network Groups supported by the National Cancer Institute.

Bradley is certified by the American Board of Radiology in radiation oncology. He was named a fellow of the American Society for Radiation Oncology (ASTRO) in 2017. He served as chair of the lung/sarcoma section of oral boards with the American Board of Radiology for 10 years. He is also a founding member of the Particle Therapy Oncology Group of North America. Bradley is the author of over 180 peer-reviewed publications.

Bradley has been nominated to hold the James Keller Chair in Radiation Oncology at Emory.